Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Poweray Biotechnology is a high-tech enterprise specializing in the research, development, production, and sales of point-of-care testing (POCT) equipment and in vitro diagnostic reagents. The company is notable for its COVID‑19 antigen rapid tests, nucleic acid extraction kits, PCR test kits, HbA1C analyzers, and specific protein analyzers. Its products have received FDA/CE certification as well as ISO13485 and GMP certifications. The company claims to be the only domestic Chinese firm developing boric acid affinity chromatography core materials for HbA1c testing[2][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Poweray Biotechnology.